The MINPP1 Knockout Raji Polyclonal Cells represent a CRISPR/Cas9-mediated gene-disrupted population derived from the human Raji B-cell line. This product provides a heterogeneous pool of edited cells, offering a robust loss-of-function model for investigating the biological roles of the MINPP1 phosphatase. As a polyclonal knockout product, the cell population retains genetic diversity at the targeted locus, circumventing potential clonal artifacts and enabling physiologically relevant signaling studies.
Raji cells are an immortalized B lymphocyte line established from a Burkitt??s lymphoma tumor and maintain an Epstein-Barr virus (EBV)-positive state. These lymphoblastoid cells exhibit functional hallmarks of mature B cells, including surface immunoglobulin expression, antigen presentation capability, and the capacity to secrete antibodies. Owing to these properties, Raji cells have become a widely utilized model system in immunology research, lymphoma biology, and drug discovery endeavors.
MINPP1 encodes an inositol polyphosphate phosphatase that hydrolyzes highly phosphorylated substrates such as InsP6 and InsP5, as well as 2,3-bisphosphoglycerate. Through its catalytic activity, MINPP1 regulates intracellular inositol phosphate pools that feed into the phosphatidylinositol signaling and insulin signaling pathways. Downstream of MINPP1, the generated InsP4, InsP3, and inorganic phosphate modulate key nodes including the kinases Akt and PDK1. Within this network, MINPP1 is counterbalanced by inositol phosphate kinases like IPMK and ITPK1, and its actions intersect with PTEN-controlled phosphoinositide dynamics. By altering InsP6 levels, MINPP1 can influence cellular processes such as chromatin remodeling, mRNA export, and growth-factor-dependent signaling cascades that govern proliferation and survival.
In the context of Raji B lymphocytes, perturbation of MINPP1 function is poised to disrupt inositol polyphosphate balance, thereby affecting phosphatidylinositol-mediated signal transduction. Given the prominent role of the PI3K/Akt axis in B-cell receptor signaling and lymphoma pathogenesis, this knockout model facilitates dissection of MINPP1??s contribution to oncogenic signaling and metabolic regulation in a cancer cell environment. Additionally, the EBV-positive background offers a unique platform to explore how viral latency programs intersect with host inositol phosphate metabolism.
This knockout product is applicable to a wide range of investigations, including quantitative analysis of InsP5 and InsP6 by HPLC or mass spectrometry, phosphatase activity assays, western blotting for MINPP1 expression, and RT-qPCR profiling. Functional studies may encompass phospho-Akt signaling analyses, cell proliferation measurements, and transcriptome-wide RNA sequencing to map downstream gene regulatory changes. The model is particularly relevant for research into inositol phosphate metabolism, pontocerebellar hypoplasia, cancer cell signaling, and phosphate homeostasis. For further details or to discuss custom applications, please contact Ascent Research.
